Results: 2

1.
Fig 2

Fig 2. From: Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old.

Immunogenicity by baseline serology status.

Richard J. Hillman, et al. Clin Vaccine Immunol. 2012 February;19(2):261-267.
2.

Fig 1. From: Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old.

Quadrivalent HPV vaccine immunogenicity by world region.

Richard J. Hillman, et al. Clin Vaccine Immunol. 2012 February;19(2):261-267.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk